Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalised Care Plan for Chronic Post-Operative Pain in Breast Cancer
NCT02170415Unknown
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Jun 2014
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of pregabalin in Persistent postsurgical pain (PPSP) (2 arms), sponsored by Royal Marsden NHS Foundation Trust. Primary endpoint: Difference in pain scores at 3 months. Status: unknown.
02
Drugs
pregabalin
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on NCT02170415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02170415.